Peng Fang

Energizer
DISC Type : I

Director, Neuroscience Next Generation Therapeutics at Eli Lilly and Company

Greater Boston, United States

Overview

Peng Fang is a scientific leader with over 13 years of industrial experience in translational research across oncology, neurology, and rare genetic diseases. As Director at Eli Lilly, he specializes in designing and executing bioanalytical and biomarker strategies for diverse drug modalities. He holds a Ph. D. from Oregon Health & Science University.

His expertise encompasses a wide array of drug modalities, including small molecules, peptides, antibodies, siRNA, ASO, and AAV gene therapy.

Personality Overview

Informal

Enthusiastic

Believer

They are really good at seeing what the long-term impacts of their decisions could be.  They are friendly, approachable and love to make new connections. Unlike C or D types, they are vocal with their opinions but not so much with their questions.

Topics They Care About

Translational Research
Has a proven track record of designing and executing bioanalytical and biomarker strategies to support all stages of the drug development pipeline.
Neuroscience Therapeutics
Currently serves as the Director of Neuroscience Next Generation Therapeutics at Eli Lilly, focusing on innovative treatments for neurological disorders.
Biomarker Development
Specializes in the discovery, validation, and implementation of RNA and protein biomarker assays for preclinical and clinical programs.

Media Appearances

Peng has no verified media appearances

Work History

10-2022
Director, Neuroscience Next Generation Therapeutics at Eli Lilly and Company
3-2022 - 9-2022
Senior Advisor, Neuroscience Next Generation Therapeutics at Eli Lilly and Company
4-2020 - 2-2022
Senior Research Scientist, Neuroscience Next Generation Therapeutics at Eli Lilly and Company
5-2018 - 1-2020
Senior Scientist, Group Leader, Translational Development at Sarepta Therapeutics
3-2015 - 5-2018
Senior Scientist, Platform lead, Advanced Diagnostics at ICON Specialty Labs (formerly MolecularMD)

Education

1996 - 2002
Doctor of Philosophy (Ph.D.) from Oregon Health & Science University

More Information

Social Presence :

Prographics :

Exp : 28 Location : Greater Boston, United States Job Level : Mid-senior Designation : Director, Neuroscience Next Generation Therapeutics at Eli Lilly and Company
URL has been copied!

Insights For Selling To Peng

During A Call Or A Meeting

DO's

  • Talk about their team and how your product will help them do things better and easier
  • Talk anecdotally about the customer experience that your product offers
  • Do some small talk, ask them how things are going on their side

DONT's

  • Avoid ifs and buts, don’t talk too much about the risks etc.
  • Avoid cutting into their flow
  • Don’t assume a yes just because they have not said no

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Peng is

  • Relationship and rapport can play an important role, sometimes more than the other factors.
  • Will you ever get a clear answer from Peng

  • They will probably never say no directly, you have to make that decision yourself.

Insights For Deal Planning

    How fast (or slow) will Peng move?

  • They are not the quickest decision makers, their friendly attitude could be misleading.
  • Can Peng take some risk or not?

  • They may take certain risks that they deem unlikely of personal repercussions.

You And Peng

Personality Compatibility


Other Eli Lilly and Company Employees

Explore more public profiles from related professionals at the same organization.

More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.